1303 related articles for article (PubMed ID: 393456)
21. The effect of combined oral contraceptive steroids on the gonadotropin responses to LH-RH in lactating women with regular menstrual cycles resumed.
Ryu K; Hong SS
Contraception; 1983 Jun; 27(6):605-17. PubMed ID: 6413131
[TBL] [Abstract][Full Text] [Related]
22. Gonadotropin and estradiol secretion during the week of placebo therapy in oral contraceptive pill users.
van der Spuy ZM; Sohnius U; Pienaar CA; Schall R
Contraception; 1990 Dec; 42(6):597-609. PubMed ID: 2128047
[TBL] [Abstract][Full Text] [Related]
23. A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters: I. Effects upon sexual hormone levels.
Kuhl H; Gahn G; Romberg G; März W; Taubert HD
Contraception; 1985 Jun; 31(6):583-93. PubMed ID: 2931247
[TBL] [Abstract][Full Text] [Related]
24. Shorter pill-free interval in combined oral contraceptives decreases follicular development.
Spona J; Elstein M; Feichtinger W; Sullivan H; Lüdicke F; Müller U; Düsterberg B
Contraception; 1996 Aug; 54(2):71-7. PubMed ID: 8842582
[TBL] [Abstract][Full Text] [Related]
25. Pituitary and ovarian responsiveness to a graded gonadotropin releasing factor stimulation test in women using a low-estrogen or a regular type of oral contraceptive.
Spellacy WN; Kalra PS; Buhi WC; Birk SA
Am J Obstet Gynecol; 1980 May; 137(1):109-15. PubMed ID: 6768295
[TBL] [Abstract][Full Text] [Related]
26. A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives.
Aden U; Jung-Hoffmann C; Kuhl H
Contraception; 1998 Aug; 58(2):75-81. PubMed ID: 9773261
[TBL] [Abstract][Full Text] [Related]
27. Serum gonadotropin and ovarian steroid levels in women during administration of a norethindrone-ethinylestradiol triphasic oral contraceptive.
Ling WY; Johnston DW; Lea RH; Bent AE; Scott JZ; Toews MR
Contraception; 1985 Oct; 32(4):367-75. PubMed ID: 3935373
[TBL] [Abstract][Full Text] [Related]
28. Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist.
Ruchhoft EA; Elkind-Hirsch KE; Malinak R
Fertil Steril; 1996 Jul; 66(1):54-60. PubMed ID: 8752611
[TBL] [Abstract][Full Text] [Related]
29. Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive.
London RS; Chapdelaine A; Upmalis D; Olson W; Smith J
Acta Obstet Gynecol Scand Suppl; 1992; 156():9-14. PubMed ID: 1324557
[TBL] [Abstract][Full Text] [Related]
30. Ovarian activity during regular oral contraceptive use.
Crosignani PG; Testa G; Vegetti W; Parazzini F
Contraception; 1996 Nov; 54(5):271-3. PubMed ID: 8934059
[TBL] [Abstract][Full Text] [Related]
31. Laboratory criteria for menopause in women using oral contraceptives.
Creinin MD
Fertil Steril; 1996 Jul; 66(1):101-4. PubMed ID: 8752618
[TBL] [Abstract][Full Text] [Related]
32. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
Elomaa K; Rolland R; Brosens I; Moorrees M; Deprest J; Tuominen J; Lähteenmäki P
Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
[TBL] [Abstract][Full Text] [Related]
33. Effects of low dose oral contraceptives containing norethindrome and ethinyl estradiol on serum levels of progesterone and pituitary gonadotropins.
McGuire JL; Bariso CD; Yuliano E; Hume RJ; Pasquale SA
Contraception; 1975 Mar; 11(3):329-38. PubMed ID: 1116369
[TBL] [Abstract][Full Text] [Related]
34. Modulation of ovarian function by an oral contraceptive containing 30 micrograms ethinyl estradiol in combination with 2.00 mg dienogest.
Spona J; Feichtinger W; Kindermann C; Moore C; Mellinger U; Walter F; Gräser T
Contraception; 1997 Sep; 56(3):185-91. PubMed ID: 9347211
[TBL] [Abstract][Full Text] [Related]
35. Biphasic change in pituitary capacity induced by estrogen in hypogonadal women.
Lachelin GC; Yen SS
J Clin Endocrinol Metab; 1978 Mar; 46(3):369-73. PubMed ID: 109457
[TBL] [Abstract][Full Text] [Related]
36. Effects of combined oral contraceptive steroids on pituitary-ovarian function during the menstrual cycle of lactating women.
Ryu K; Yu HK; Kwak HM; Hong SS
Contraception; 1983 Mar; 27(3):299-310. PubMed ID: 6406140
[TBL] [Abstract][Full Text] [Related]
37. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
38. The effect of norethisterone (500 mcg) and ethinyl estradiol (35 mcg) capsules on the pituitary-ovarian axis.
Nuttall ID; Elstein M; Fahmy DR
Contraception; 1982 May; 25(5):463-9. PubMed ID: 6809424
[TBL] [Abstract][Full Text] [Related]
39. Changes in physiological, EEG and psychological parameters in women during the spontaneous menstrual cycle and following oral contraceptives.
Becker D; Creutzfeldt OD; Schwibbe M; Wuttke W
Psychoneuroendocrinology; 1982; 7(1):75-90. PubMed ID: 7100370
[TBL] [Abstract][Full Text] [Related]
40. Opioid regulation of pituitary gonadotropins and prolactin in women using oral contraceptives.
Snowden EU; Khan-Dawood FS; Dawood MY
Am J Obstet Gynecol; 1986 Feb; 154(2):440-4. PubMed ID: 3080893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
